Institute Scholars

Institute scholar Monther Abu-Remaileh is a co-PI with Michael Bassik and Marius Wernig on Team Lashuel, led by Hilal Lashuel, one of the teams funded by Aligning Science Across Parkinson’s and The Michael J. Fox Foundation for Parkinson’s Research through a $261 million effort to advance Parkinson’s research and treatments.

Dassama was recognized for her innovative research, potential for future impact, and dedication to advancing scientific knowledge.

The same trick could also be used against them

Dassama was recognized for her work characterizing lipid-binding proteins in bacteria for mitigating multidrug resistance.

Institute Scholar Jonathan Long & team studied the extreme metabolism of pythons—snakes that gorge themselves and then go months without eating—leading to discovery of an appetite-reducing molecule that could be a starting point for new weight-loss drugs.

Tag along for a stroll with some of the people behind the research, education and care at Stanford Medicine.

Tag along for a stroll with some of the people behind the research, education and care at Stanford Medicine

Institute Scholar Monther Abu–Remaileh receives the ASBMB 2026 Walter A. Shaw Young Investigator Award in Lipid Research

The two-year fellowships are awarded to early-career scientists whose accomplishments mark them as the next generation of leaders.

Ian Guldner (Tony Wyss-Coray lab), Carolyn Bertozzi, Monther Abu-Remaileh, and team has published work exploring the relationship between synapse loss and defective protein recycling in the aging brain, offering new insights into brain health and disease risk during aging.

Lab of Institute Scholar Monther Abu-Remaileh has built an atlas of proteins associated with lysosomes in different brain cell types that researchers hope will shed light on neurodegenerative disease.

A database of lysosomal proteins is already guiding researchers in studying how brain cells’ waste and recycling systems work – or don’t – in Alzheimer’s and other neurological diseases.

Carolyn Bertozzi studies sugars on the surface of cells to better understand their involvement in diseases, including cancer. This work aims to add to our fundamental knowledge of biology while also informing new medical treatments.

The development of antibody-lectin chimeras, which started in the lab of Stanford chemist Carolyn Bartozzi, shows promise in blocking the defenses put up by cancer cells and allowing the immune system to attack the diseased cells more effectively.

Research shows that ecDNA circles hitchhike on chromosomes to spread to daughter cells. Blocking these circles could enable the development of new cancer therapies.

Lingyin Li is a researcher on the front lines of the fight against cancer. She explains how her immunotherapy work is unmasking hidden cancers and developing new drugs to kill them.

The Coalition for Epidemic Preparedness (CEPI) awarded the Peter Kim Lab $18 million to create a single, effective vaccine that protects against a broad range of filoviruses.

Paul Mischel's work promises to reshape the future of cancer care and save countless lives.